22.418 articles found

Methods for the treatment of synucleinopathies

LANSBURY PETER T, LIU ZHIHUA.

· 2005-03-18

Methods for the treatment of synucleinopathies (Lansbury)

LANSBURY PETER T, LIU ZHIHUA.

· 2005-03-18

METHODS FOR THE TREATMENT OF SYNUCLEINOPATHIES

LANSBURY PETER T, LIU ZHIHUA.

· 2005-03-18

Cortico-cortical coupling in Parkinson's disease and its modulation by therapy.

Silberstein P, Pogosyan A, Kühn AA, Hotton G, Tisch S, Kupsch A, Dowsey-Limousin P, Hariz MI, Brown P.

Brain · 2005-03-17

DOI: 10.1093/brain/awh480PMID: 15774503

Sensitivity analysis for selecting therapy parameter sets

HERUTH KENNETH T, MIESEL KEITH A.

· 2005-03-16

Sensitivity analysis for selecting therapy parameter sets

HERUTH KENNETH T, MIESEL KEITH A.

· 2005-03-16

Pharmacotherapy of Parkinson's disease in Germany.

Möller JC, Körner Y, Dodel RC, Meindorfner C, Stiasny-Kolster K, Spottke A, Krüger HP, Oertel WH.

J Neurol · 2005-03-16

DOI: 10.1007/s00415-005-0784-1PMID: 15765268

Treatment of dyskinesia

CROSSMAN ALAN, HILL MICHAEL, BROTCHIE JONATHAN, SILVERDALE MONTAGUE.

· 2005-03-10

DIAZABICYCLIC COMPOUNDS USEFUL IN THE TREATMENT OF CNS AND OTHER DISORDERS.

O'DONELL CHRISTOPHER JOHN.

· 2005-03-09

Peculiarities of L: -DOPA treatment of Parkinson's disease.

Kostrzewa RM, Nowak P, Kostrzewa JP, Kostrzewa RA, Brus R.

Amino Acids · 2005-03-09

DOI: 10.1007/s00726-005-0162-4PMID: 15750845

Sleep and sleepiness in patients with Parkinson's disease before and after dopaminergic treatment.

Kaynak D, Kiziltan G, Kaynak H, Benbir G, Uysal O.

Eur J Neurol · 2005-03-01

DOI: 10.1111/j.1468-1331.2004.00971.xPMID: 15693809

Early administration of entacapone prevents levodopa-induced motor fluctuations in hemiparkinsonian rats.

Marin C, Aguilar E, Bonastre M, Tolosa E, Obeso JA.

Exp Neurol · 2005-03-01

DOI: 10.1016/j.expneurol.2004.10.008PMID: 15698633